Melanie Peralta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Melanie Peralta has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Solovyov
Computational Oncology, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
23 shared publications - Amir Hosseini
Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK
23 shared publications - Amit Manulal Oza
Princess Margaret Cancer Centre 2 Division of Medical Oncology and Hematology , Toronto, Canada
23 shared publications - Aneil Srivastava
Department of Microbiology, Immunology and Tropical Medicine, The George Washington University Cancer Center, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia
23 shared publications - Anjelica Hodgson
University of Toronto
23 shared publications - Aobo He
Department of Medical Biophysics, University of Toronto, Toronto, Canada
23 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S2: Guide RNAs used for CRISPR gene editing in this study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S2: Guide RNAs used for CRISPR gene editing in this study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S7 that shows the impact of viral mimicry conditioning on therapeutic approaches
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S7 that shows the impact of viral mimicry conditioning on therapeutic approaches
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S3 shows that p53 loss diminishes H3K9me3 at transcriptionally upregulated repetitive elements
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S3 shows that p53 loss diminishes H3K9me3 at transcriptionally upregulated repetitive elements
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S4: Primer sequences used in this study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S4: Primer sequences used in this study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S6 that shows Acquisition of viral mimicry tolerance affects antitumor adaptive immune responses
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S6 that shows Acquisition of viral mimicry tolerance affects antitumor adaptive immune responses
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S2 shows that Trp53 mutation facilitates transcriptional dysregulation of retrotransposons in murine oviductal epithelial cells and ovarian surface epithelial cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S2 shows that Trp53 mutation facilitates transcriptional dysregulation of retrotransposons in murine oviductal epithelial cells and ovarian surface epithelial cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S3: Antibodies used in this study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S3: Antibodies used in this study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S1: Patient cohort characteristics
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Table S1: Patient cohort characteristics
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S5 that shows Viral mimicry conditioning diminishes Type I IFN
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S5 that shows Viral mimicry conditioning diminishes Type I IFN
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S1 Shows that TP53 mutation facilitates transcriptional dysregulation of retrotransposons in STICs and human fallopian tube secretory epithelial cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
Figure S1 Shows that TP53 mutation facilitates transcriptional dysregulation of retrotransposons in STICs and human fallopian tube secretory epithelial cells